2004 Annual Meeting | Acute Stroke Management

Date Monday 04/26/04

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Lawrence R. Wechsler, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should become familiar with the pathophysiology of acute stroke, including current and future treatments; understand the utility of imaging in the acute stroke setting; and learn the essential elements of stroke centers.

The American Board of Psychiatry and Neurology has reviewed Acute Stroke Management and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 02:40 PM		Pathophysiology of Acute Stroke Tudor G. Jovin, MD
02:40 PM - 03:05 PM		Thrombolysis and Neuroprotection - What's New? Lawrence R. Wechsler, MD, FAAN
03:05 PM - 03:30 PM		Interventional Therapy for Acute Stroke Anthony J. Furlan, MD, FAAN
03:30 PM - 03:45 PM		Questions and Answers
03:45 PM - 04:00 PM		Break
04:00 PM - 04:25 PM		Combination Therapy James C. Grotta, MD, FAAN
04:25 PM - 04:50 PM		Imaging in Acute Stroke : Present and Future Walter J. Koroshetz, MD, FAAN
04:50 PM - 05:15 PM		Stroke Centers and Certification Mark J. Alberts, MD, FAAN
05:15 PM - 06:00 PM		Acute Stroke Case Reviews

Faculty Disclosures
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
	No disclosure on file
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Anthony J. Furlan, MD, FAAN	No disclosure on file
James C. Grotta, MD, FAAN	Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Mark J. Alberts, MD, FAAN	No disclosure on file
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.

��ɫ��

��ɫ��